CareDx Q2 adjusted revenue up 14% YoY to $90.5M; narrows FY guidance; appoints new CFO

CareDx, Inc.

2025-Q2 EPS reported -$0.35 revenue$171,364,000

Q2 adjusted revenue $90.5M (+14% YoY); GAAP revenue $86.7M (-6% YoY) due to $3.8M aged receivable write-off.
Testing services volume ~49,500 (+13% YoY); AlloSure Kidney volume up ~20% YoY.
GAAP net loss $8.6M ($0.16/sh) vs $4.6M loss; non-GAAP net income $5.6M ($0.10/sh) vs $13.6M.
Adjusted EBITDA $9.1M (excl. $3.8M write-off) vs prior year loss $0.3M.
CFO change: Nathan Smith appointed, effective Aug 7, 2025; Abhishek Jain retired; Smith receives $400K salary, RSUs, PSUs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.